Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$6.06 - $12.86 $42,420 - $90,020
-7,000 Reduced 40.94%
10,100 $61,000
Q2 2022

Aug 15, 2022

BUY
$8.35 - $21.89 $39,245 - $102,883
4,700 Added 37.9%
17,100 $179,000
Q1 2022

May 16, 2022

SELL
$16.97 - $31.93 $1.53 Million - $2.87 Million
-89,900 Reduced 87.88%
12,400 $256,000
Q4 2021

Feb 14, 2022

BUY
$25.61 - $41.78 $2.09 Million - $3.41 Million
81,500 Added 391.83%
102,300 $3.2 Million
Q3 2021

Nov 15, 2021

SELL
$19.65 - $27.99 $66,810 - $95,166
-3,400 Reduced 14.05%
20,800 $484,000
Q1 2021

May 17, 2021

SELL
$18.08 - $28.8 $1.34 Million - $2.13 Million
-74,000 Reduced 75.36%
24,200 $554,000
Q4 2018

Feb 14, 2019

BUY
$14.06 - $22.57 $967,328 - $1.55 Million
68,800 Added 234.01%
98,200 $1.64 Million
Q3 2018

Nov 14, 2018

BUY
$13.35 - $19.1 $184,230 - $263,580
13,800 Added 88.46%
29,400 $504,000
Q2 2018

Aug 14, 2018

BUY
$10.35 - $16.45 $161,460 - $256,620
15,600 New
15,600 $225,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $199M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.